Dysregulated Post-Transcriptional Control of COX-2 Gene Expression in Cancer
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
635-646
Author(s):
Dan A. Dixon
Cyclooxygenase-2: Potential Role in Regulation of Drug Efflux and Multidrug Resistance Phenotype
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
647-657
Author(s):
A. Sorokin
Oxidative Metabolism of Endocannabinoids by COX-2
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
659-667
Author(s):
Kevin R. Kozak, Jeffery J. Prusakiewicz and Lawrence J. Marnett
Preface [Hot topic: Potential Therapeutic Agents for Parkinsons Disease (Executive Editor: Masato Asanuma)]
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
668-668
Author(s):
Masato Asanuma
Minocycline: Neuroprotective Mechanisms in Parkinsons Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
679-686
Author(s):
M. Thomas and W. D. Le
Neuroprotective Effects of Nonsteroidal Anti-inflammatory Drugs on Neurodegenerative Diseases
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
695-700
Author(s):
M. Asanuma, I. Miyazaki and N. Ogawa
Perspectives for Drug Intervention in Amyloid Diseases
Journal:
Current Drug Targets
Volume:
5
Page:
151-158
Author(s):
Simon Kolstoe and Steve Wood
Neurokinin Peptides and Neurokinin Receptors as Potential Therapeutic Intervention Targets of Basal Ganglia in the Prevention and Treatment of Parkinsons Disease
Journal:
Current Drug Targets
Volume:
5
Page:
197-206
Author(s):
L.- W. Chen, K. K.L. Yung and Y S Chan
A Mechanistic Overview on Male Infertility and Germ Cell Cancers
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
449-469
Author(s):
Pascale Crepieux, Charlotte Lecureuil, Sebastien Marion, Elodie Kara, Vincent Piketty, Nadine Martinat, Florian Guillou, Dominique Royere and Eric Reiter
Alterations of Sex Differentiation in Males: From Candidate Genes to Diagnosis and Treatments
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
501-511
Author(s):
Harry Ostrer